AT2221 Pill: gray & white, capsule/oblong, 18mm
Generic Name: miglustat
The pill with imprint AT2221 (Gray & White, Capsule/Oblong, 18mm) has been identified as Opfolda 65 mg and is used for Pompe Disease. It belongs to the drug class miscellaneous metabolic agents and is not a controlled substance.
Images for AT2221
Opfolda
- Generic Name
- miglustat
- Imprint
- AT2221
- Strength
- 65 mg
- Color
- Gray & White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous metabolic agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amicus Therapeutics, Inc.
- National Drug Code (NDC)
- 71904-0300
See also:
More about Opfolda (miglustat)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.